Targeting PARP in prostate cancer: Novelty, pitfalls, and promise

Phillip L. Palmbos, Maha H. Hussain

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

We will review how PARP inhibitors function as a class, review the molecular features that sensitize cancer cells to this therapy, and discuss the data supporting its potential for patients with prostate cancer.

Original languageEnglish (US)
JournalONCOLOGY (United States)
Volume30
Issue number5
StatePublished - May 15 2016

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Targeting PARP in prostate cancer: Novelty, pitfalls, and promise'. Together they form a unique fingerprint.

Cite this